These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7592261)

  • 21. Given the multifaceted nature of ADHD, namely its physiologic, cognitive, psychological, and behavioral manifestations, multimodal approaches to treatment are advocated. Introduction.
    Markowitz JS; Patrick KS
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S37-8. PubMed ID: 18480675
    [No Abstract]   [Full Text] [Related]  

  • 22. Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified.
    Orsagh-Yentis DK; Wink LK; Stigler KA; Erickson CA; McDougle CJ
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):643-5. PubMed ID: 22136097
    [No Abstract]   [Full Text] [Related]  

  • 23. Dysthymic disorder contributes to oppositional defiant behaviour in children with Attention Deficit Hyperactivity Disorder, combined type (ADHD-CT).
    Vance A; Sanders M; Arduca Y
    J Affect Disord; 2005 Jun; 86(2-3):329-33. PubMed ID: 15935256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of comorbid oppositional or conduct problems on attention-deficit hyperactivity disorder.
    Kuhne M; Schachar R; Tannock R
    J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1715-25. PubMed ID: 9401333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buspirone Abuse by Insufflation: A Case Report.
    Swigart A
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):89-90. PubMed ID: 33208707
    [No Abstract]   [Full Text] [Related]  

  • 27. I have heard that buspirone regularly affects various blood tests. Is this so?
    Shader RI
    J Clin Psychopharmacol; 1996 Apr; 16(2):194. PubMed ID: 8690840
    [No Abstract]   [Full Text] [Related]  

  • 28. Anxiolytics, adrenergic agents, and naltrexone.
    Riddle MA; Bernstein GA; Cook EH; Leonard HL; March JS; Swanson JM
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):546-56. PubMed ID: 10230186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxiety.
    Sramek JJ; Hong WW; Hamid S; Nape B; Cutler NR
    Depress Anxiety; 1999; 9(3):131-4. PubMed ID: 10356651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of anxiolytics on blood sugar level in rabbits.
    Dixit RK; Puri JN; Sharma MK; Jain IP; Singh S; Ansari NA; Singh SP
    Indian J Exp Biol; 2001 Apr; 39(4):378-80. PubMed ID: 11491585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of buspirone in alcohol dependence: a review.
    Malec TS; Malec EA; Dongier M
    Alcohol Clin Exp Res; 1996 Aug; 20(5):853-8. PubMed ID: 8865960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Dolan C; Hughes S; Mick E; Monuteaux MC; Faraone SV
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Family functioning and psychosocial characteristics in children with attention deficit hyperactivity disorder with comorbid oppositional defiant disorder or conduct disorder].
    Kiliç BG; Sener S
    Turk Psikiyatri Derg; 2005; 16(1):21-8. PubMed ID: 15793695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotropic drugs and preschoolers.
    Rey JM; Walter G; Hazell PL
    Med J Aust; 2000 Aug; 173(4):172-3. PubMed ID: 11008585
    [No Abstract]   [Full Text] [Related]  

  • 35. Stiff Person Syndrome Presenting After the Initiation of Buspirone.
    Sablaban I; Prabhakar D
    Psychosomatics; 2017; 58(6):664-668. PubMed ID: 28602446
    [No Abstract]   [Full Text] [Related]  

  • 36. Is imipramine or buspirone treatment effective in patients wishing to discontinue long-term benzodiazepine use?
    Sontheimer DL; Ables AZ
    J Fam Pract; 2001 Mar; 50(3):203. PubMed ID: 11252203
    [No Abstract]   [Full Text] [Related]  

  • 37. An open study of buspirone augmentation of neuroleptics in patients with schizophrenia.
    Sirota P; Epstein B; Benatov R; Sousnostzky M; Kindler S
    J Clin Psychopharmacol; 2001 Aug; 21(4):454-5. PubMed ID: 11476132
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response.
    Navinés R; Martín-Santos R; Gómez-Gil E; Martínez de Osaba MJ; Imaz ML; Gastó C
    Psychoneuroendocrinology; 2007 May; 32(4):411-6. PubMed ID: 17337123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The use of buspirone in clinical practice].
    Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(4):83-87. PubMed ID: 26288293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
    Pliszka SR
    J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.